This is for the skate nerds out there. Got a favorite shape? A preferred wheelbase? Been wanting to just try something ...

The writer draws on her experiences leading apolitical focus groups to suggest ways we might be more moderate in conversing ...

Abstract: Although enormous domain adaptation (DA) approaches have been proposed for cross-scene hyperspectral image (HSI) classification, the majority of DA methods strongly depend on much prior ...

There will be a new venue to enjoy soon for a popular annual model fair. Saturday and Sunday, November 1-2 will see the Elgin Model Fair - run by Elgin Model Railway Club (EMRC) - attract exhibitors ...

Cindy's beau, who she has not named, got down on one knee in church and presented the model with a ring, before standing up and wrapping her in an embrace. Cindy captioned the video: 'God works in ...

China aims to lead global artificial intelligence by 2030, with its AI platforms now nearly matching US capabilities. But without top-tier chips and free expression, can Beijing really win the race?

Lia Smith ’26 was reported missing to the Middlebury Police Department on Sunday afternoon. Smith's father filed the report after not hearing back from her via cell phone and communicating with her ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up for Dispatches, a newsletter that spotlights wrongdoing around the country, to receive our stories in your inbox every ...

Abstract: Due to the lack of prior knowledge about unknown classes during training, existing methods for cross-domain open-set image recognition typically rely on threshold-based solutions. However, ...

Neelam Kaur Gill, the first-ever Punjabi model to walk for the legendary Victoria’s Secret Fashion show, graced the ramp this year for the second time in a row. A British fashion model and activist of ...

Results presented by AstraZeneca from its phase 3 trial of Imfinzi in patients with high-risk, non-muscle invasive bladder cancer (NMIBC) suggest the PD-L1 inhibitor measures up to Pfizer’s PD-1 ...